Long way
The Western News - Feb 02 12:24 PM
We’ve come a long way since the first copy of H.R. 1283 crossed my desk. In March 1999, that was the House bill that has since evolved into The Fairness in Asbestos Injury Resolution Act or FAIR. It’s also correctly referred to as the asbestos company bail-out bill.Save to My Web
Alfacell Revises Guidance on Patient Enrollment for the ONCONASE Confirmatory Phase IIIb Clinical Trial in Unresectable
[Press Release] PR Newswire via Yahoo! Finance - Jan 30 5:45 AM
Alfacell Corporation today provided the following update on the Company’s international, confirmatory Phase IIIb trial evaluating ONCONASE , the Company’s lead investigational drug candidate, as a treatment for unresectable malignant mesothelioma :Save to My Web
Asbestos Still Being Used In USA, Despite The Known Risks
Medical News Today - Feb 06 8:17 AM
The February edition of CancerWire focuses on the continued presence of a carcinogen that will stun many Americans - asbestos the well known carcinogenic mineral is still being used in the U.S. and this deadly mineral can be found in over 30 million homes and schools. These revelations and others were provided during a recent interview with Linda Reinstein of the Asbestos Disease Awareness Save to My Web
Can you catch cancer?
Guardian Unlimited - Jan 24 3:17 AM
Doctors believe that infections, even simple coughs and colds, can trigger everything from childhood leukaemia to cervical cancer. Should we be worried? Sarah Boseley investigates.Save to My Web
INNOVIVE Pharmaceuticals Licenses WT1 Peptide Cancer Immunotherapeutic from Memorial Sloan-Kettering Cancer Center
[Press Release] Business Wire via Yahoo! Finance - Jan 09 5:54 AM
NEW YORK—-Jan. 9, 2006–INNOVIVE Pharmaceuticals Inc., a biopharmaceutical company headquartered in Manhattan, announced today that it has licensed worldwide development rights for a WT1 heteroclitic peptide immunotherapeutic from Memorial Sloan-Kettering Cancer Center in New York.Save to My Web